FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
International audience
Publications
View AllFOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Adjuvant therapy with a modified FOLFIRINOX regimen led to significantly longer survival than gemcitabine among patients with resected pancreatic cancer, at the expense of a hig...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- FR
- Publications
- 2
- Citations
- 10,113
External Links
Identifiers
- ROR
- https://ror.org/00dt6a694